Regeneron Pharmaceuticals (REGN) Q2 2019 Earnings

7MayConfirmed
Q3 2018
Q4 2018
Q1 2019
Q2 2019
4.45
5.25
6.04
6.84

Details

Expected EPS
5.45
Actual EPS
4.45
Surprise EPS
-1
Surprise Percent
+18.35%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 4.45 per share for Q2 2019.

0 Comments

Share your thoughts